Pancreatic Cancer Research

ResearcherNo recent work listed

Lei Yuan

Matched on ORCID iD 0009-0006-1378-7000; OpenAlex author ID A5100390970.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 4

  1. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells. Last author DOI 10.1016/j.bmcl.2022.129087↗
  2. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. First author DOI 10.1016/j.cbi.2022.109811↗
  3. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation. Co-author DOI 10.1016/j.bioorg.2020.103679↗
  4. EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. Co-author DOI 10.3892/etm.2015.2684↗

Closest collaborators

The 8 strongest of 8 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Enlong Ma · 3 shared papers, 2020–2023
  2. Juanping Zhao · 2 shared papers, 2022–2023
  3. Yanchun Li · 2 shared papers, 2020–2022
  4. Haoqiang Huang · 1 shared paper, 2023
  5. Haoxuan Song · 1 shared paper, 2020
  6. Xiulan Peng · 1 shared paper, 2015
  7. Weiguo Dong · 1 shared paper, 2015
  8. Mengyao Ji · 1 shared paper, 2015

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.